Methotrexate
NDC 61703-124, Methotrexate, injection, solution, from Hospira, Inc..
- Product NDC
- 61703-124
- Status
- Listed
- Labeler
- Hospira, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR, INTRATHECAL, INTRAVENOUS, SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA011719
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/61703-124 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- METHOTREXATE SODIUM25 mg/mL
Pharmacologic classes
Folate Analog Metabolic Inhibitor [EPC]; Folic Acid Metabolism Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 61703-124-40 | 61703012440 | 1 VIAL, SINGLE-DOSE in 1 CARTON (61703-124-40) / 40 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/bd287e89-32f9-4396-95fa-4b562869f476Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=61703-124
Use it
Look up 61703-124 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/61703-124 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 61703-124. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.